[{"Assets_0_Q3_USD":1106909000.0,"CommonStockSharesOutstanding_0_Q3_shares":52462936.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":99338000.0,"NetIncomeLoss_1_Q3_USD":28860000.0,"NetIncomeLoss_3_Q3_USD":79927000.0,"StockholdersEquity_0_Q3_USD":557257000.0,"EarningsPerShareBasic_1_Q3_USD":0.55,"EarningsPerShareBasic_3_Q3_USD":1.53,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52453384.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":52392232.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]